Oric Pharmaceuticals Inc
NASDAQ:ORIC

Watchlist Manager
Oric Pharmaceuticals Inc Logo
Oric Pharmaceuticals Inc
NASDAQ:ORIC
Watchlist
Price: 8.25 USD -2.14% Market Closed
Market Cap: 803.5m USD

Operating Margin
Oric Pharmaceuticals Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-148m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Oric Pharmaceuticals Inc
Glance View

Market Cap
802.5m USD
Industry
Biotechnology

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. The company is headquartered in South San Francisco, California and currently employs 78 full-time employees. The company went IPO on 2020-04-24. The firm is focused on developing a diverse pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its experience within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its product candidates include ORIC-101, ORIC-533, ORIC-944 and ORIC-114. The Company’s ORIC-101 is a potent and selective small-molecule antagonist of the glucocorticoid receptor (GR), which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. The Company’s second product candidate, ORIC-533, is an orally bioavailable, small-molecule inhibitor of CD73, a key node in the adenosine pathway in resistance to chemotherapy-and immunotherapy-based treatment regimens. Its ORIC-944, is being developed for prostate cancer and breast cancer.

ORIC Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-148m
/
Revenue
0
What is the Operating Margin of Oric Pharmaceuticals Inc?

Based on Oric Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top